(Q34107884)

31 July 2017

1 reference

title

Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens (English)

1 reference

chronic lymphocytic leukemia

31 July 2017

0 references

1 reference

1

Champlin R

1 reference

31 July 2017

3

Giralt S

1 reference

31 July 2017

4

Khouri I

1 reference

31 July 2017

2

van Besien K

1 reference

31 July 2017

1 March 2000

1 reference

31 July 2017

Current Oncology Reports

1 reference

31 July 2017

2

1 reference

31 July 2017

2

1 reference

31 July 2017

182-191

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-000-0092-y

31 July 2017

0 references

cites work

Chronic leukemias: oncogenes, chromosomes, and advances in therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11912-000-0092-Y

Chronic lymphocytic leukemia: new insights into biology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-000-0092-Y

HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-000-0092-Y

Prognostic value of serum beta-2 microglobulin in low-grade lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-000-0092-Y

Treatment of resistant mantle cell lymphoma with allogeneic bone marrow transplantation

21 January 2018

1 reference

12 December 2020

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

12 December 2020

Rearrangement of T-cell delta locus in lymphoproliferative disorders

1 reference

12 December 2020

Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high-risk" disease?

1 reference

12 December 2020

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

12 December 2020

Allogeneic blood stem cell transplantation in advanced hematologic cancers

1 reference

12 December 2020

Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent

1 reference

12 December 2020

High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy

1 reference

12 December 2020

Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission

1 reference

12 December 2020

Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies

1 reference

12 December 2020

A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the 'tumor score'

1 reference

12 December 2020

Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual disease

1 reference

12 December 2020

Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial

1 reference

12 December 2020

National Heart, Lung, and Blood Institute (NHLBI) workshop on the importance of minor histocompatibility antigens in marrow transplantation. September 16-17, 1996; Bethesda, Maryland

1 reference

12 December 2020

Impact of age on outcome of patients with cancer undergoing autologous bone marrow transplant

1 reference

12 December 2020

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients

1 reference

12 December 2020

Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants

1 reference

12 December 2020

High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma

1 reference

12 December 2020

Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms

1 reference

12 December 2020

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

1 reference

12 December 2020

Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect

1 reference

12 December 2020

Prognosis of aggressive lymphomas: a study of five prognostic models with patients included in the LNH-84 regimen

1 reference

12 December 2020

Karnofsky Memorial Lecture. Marrow transplantation for malignant diseases

1 reference

12 December 2020

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

12 December 2020

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group

1 reference

12 December 2020

Bone marrow transplants for chronic lymphocytic leukaemia

1 reference

12 December 2020

Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes

1 reference

12 December 2020

Minor histocompatibility antigen-specific cytotoxic T cell lines, capable of lysing human hematopoietic progenitor cells, can be generated in vitro by stimulation with HLA-identical bone marrow cells

1 reference

12 December 2020

High-dose chemotherapy, fractionated total-body irradiation, and allogeneic marrow transplantation for malignant lymphoma

1 reference

12 December 2020

Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect

1 reference

12 December 2020

Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma

1 reference

12 December 2020

Advances in the biology and treatment of B-cell chronic lymphocytic leukemia

1 reference

12 December 2020

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma

1 reference

12 December 2020

Survival after relapse of low-grade non-Hodgkin's lymphoma: implications for marrow transplantation

1 reference

12 December 2020

A Phase 1-11 Study of High-Dose Thiotepa, Busulfan and Cyclophosphamide as a Preparative Regimen for Autologous Transplantation for Malignant Lymphoma

1 reference

12 December 2020

Mantle cell lymphoma: a clinicopathologic study of 80 cases

1 reference

12 December 2020

Allogeneic hematopoietic transplantation as adoptive immunotherapy. Induction of graft-versus-malignancy as primary therapy

1 reference

12 December 2020

The role of minor histocompatibility antigens in GVHD and rejection: a mini-review.

1 reference

12 December 2020

Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia

1 reference

12 December 2020

Treatment of non-Hodgkin's lymphoma

1 reference

12 December 2020

Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia

1 reference

12 December 2020

Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma

1 reference

12 December 2020

Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease

1 reference

12 December 2020

Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma

1 reference

12 December 2020

Allogeneic bone marrow transplantation for low-grade lymphoma

1 reference

12 December 2020

Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma

1 reference

12 December 2020

Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease

1 reference

12 December 2020

Graft-versus-leukemia reactions after bone marrow transplantation

1 reference

12 December 2020

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

1 reference

12 December 2020

Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma

1 reference

12 December 2020

High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity

1 reference

12 December 2020

Bcl-2 initiates a new category of oncogenes: regulators of cell death

1 reference

12 December 2020

Prognostic factors in follicular lymphomas

1 reference

12 December 2020

Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma

1 reference

12 December 2020

Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities

1 reference

12 December 2020

Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor.

1 reference

12 December 2020

High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission

1 reference

12 December 2020

Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma.

1 reference

12 December 2020

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment

1 reference

12 December 2020

Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma

1 reference

12 December 2020

Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia

1 reference

12 December 2020

Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center

1 reference

12 December 2020

Minor histocompatibility antigens.

1 reference

12 December 2020

Fludarabine: a new agent with major activity against chronic lymphocytic leukemia

1 reference

12 December 2020

Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor

1 reference

12 December 2020

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

12 December 2020

Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation

1 reference

12 December 2020

Allogeneic bone marrow transplantation for poor-prognosis non-Hodgkin's lymphoma

1 reference

12 December 2020

Clinical staging of chronic lymphocytic leukemia

1 reference

12 December 2020

Clinical and molecular remission after allogeneic blood cell transplantation in a patient with mantle-cell lymphoma

1 reference

12 December 2020

Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients.

1 reference

12 December 2020

Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.

1 reference

12 December 2020

Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia

1 reference

12 December 2020

Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs

1 reference

12 December 2020

Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP

1 reference

12 December 2020

Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies

1 reference

12 December 2020

Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model

1 reference

12 December 2020

Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data

1 reference

12 December 2020

Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group

1 reference

12 December 2020

Minor histocompatibility antigens and marrow transplantation

1 reference

12 December 2020

Treatment of hypogammaglobulinaemia in chronic lymphocytic leukaemia by low-dose intravenous gammaglobulin

1 reference

12 December 2020

Minor histocompatibility antigens

1 reference

12 December 2020

Bone marrow transplantation in patients aged 45 years and older

1 reference

12 December 2020

High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma

1 reference

12 December 2020

Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus

1 reference

12 December 2020

Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management.

1 reference

12 December 2020

Genetic abnormalities in chronic lymphocytic leukemia and their clinical and prognostic implications

1 reference

12 December 2020

Molecular biology of lymphomas

1 reference

12 December 2020

Allogeneic bone marrow transplantation in adults with Burkitt's lymphoma or acute lymphoblastic leukemia in first complete remission

1 reference

12 December 2020

Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts

1 reference

12 December 2020

Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma

1 reference

12 December 2020

Management of the low-grade non-Hodgkin's lymphomas

1 reference

12 December 2020

Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms

1 reference

12 December 2020

Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens

1 reference

12 December 2020

Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results

1 reference

12 December 2020

Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma

1 reference

12 December 2020

Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients

1 reference

12 December 2020

How does bone-marrow transplantation cure leukaemia?

1 reference

12 December 2020

Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.

1 reference

12 December 2020

Prognostic factors and clinical staging in chronic lymphocytic leukemia

1 reference

12 December 2020

Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy

1 reference

12 December 2020

Outcome after allogeneic bone marrow transplant for leukemia in older adults

1 reference

12 December 2020

Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma

1 reference

12 December 2020

Natural history of and therapy for the indolent non-Hodgkin's lymphomas.

1 reference

12 December 2020

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

1 reference

12 December 2020

Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation

1 reference

12 December 2020

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

12 December 2020

Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma

1 reference

12 December 2020

CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation

1 reference

12 December 2020

Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantation.

1 reference

12 December 2020

Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma

1 reference

12 December 2020

Excessive production of transforming growth factor-beta by bone marrow stromal cells in B-cell chronic lymphocytic leukemia inhibits growth of hematopoietic precursors and interleukin-6 production

1 reference

12 December 2020

Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma

1 reference

12 December 2020

Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors

1 reference

12 December 2020

Rearrangements of genes for the antigen receptor on T cells as markers of lineage and clonality in human lymphoid neoplasms

1 reference

12 December 2020

10.1007/S11912-000-0092-Y

Identifiers

DOI

1 reference

PubMed ID

11122842

Dimensions Publication ID

31 July 2017

0 references

1 reference

PubMed ID

11122842